-
07:59 - 08:40
Session IV: Teaching Brachytherapy
Session IV: Teaching Brachytherapy
Moderator : Thu Van Nguyen, MDDiscuss innovations in brachytherapy teaching strategies
Each talk includes a 5 mn question
-
14:25 - 14:35
Session VII: Breast Cancer
Interstitial Brachytherapy for Breast Conservation after Recurrence
Speaker: Marjory Jolicoeur, MDExplain the subtleties of an adequate treatment
Discuss this treatment alternative with patients
-
07:30 - 08:00
-
08:00 - 08:10
-
08:10 - 08:30
Session I: Prostate Cancer
The Rise of HDR Brachytherapy for Prostate Cancer
Speaker: Gerard Morton, MDExplain the history of brachytherapy for prostate cancer
Review the LDR brachytherapy era
Describe the beginnings of HDR brachytherapy
Explain the characteristics and the differences between HDR and LDR brachytherapy
Enumerate HDR brachytherapy indications
Describe the statistics of the increased use of HDR brachytherapy
-
08:30 - 08:50
Session I: Prostate Cancer
Increased Use of MRI for Patient Selection
Speaker: André-Guy Martin, MDDescribe the advantages of MRI over CT-scan
Explain the use of MRI for the selection of patients for active surveillance
Identify the nodule and boost the DIL
-
08:50 - 09:20
Session I: Prostate Cancer
Use of PSMA PET-CT for Patient Selection
Speaker: Stephan Probst, MDExplain the science behind PSMA PET
Estimate the sensitivity and specificity of this exam
Define the optimal patient for PSMA PET
Use the PSMA PET to find the nodule and target the DIL
-
09:20 - 09:40
Session I: Prostate Cancer
Predictive Value of Gene Expression in Localized Prostate cancer
Speaker: Dan Lin, MDIdentify the biomarkers for prostate cancer
Analyze the Predictive value of biomarkers
Explain Cell cycle progression markers targeted by radiotherapy
Explain how a genomic test may help in making a better treatment decision
Use gene expression markers for reclassification of intermediate risk prostate cancer
-
09:40 - 10:00
Session I: Prostate Cancer
HDR Brachytherapy Monotherapy: Are we There Yet?
Speaker: Alvaro Martinez, MDReview the literature
Explain the toxicities and compare them to LDR toxicities
Compare toxicities to EBRT or EBRT combined with brachytherapy
Estimate Disease control
-
10:00 - 10:20
-
10:20 - 10:40
Session I: Prostate Cancer
Androgen Deprivation Combined with HDR Brachytherapy: When, Why, and How?
Speaker: Carl Salembier, MDReview the literature supporting androgen deprivation therapy in combination with brachytherapy
Explain its use in prostate volume reduction
Discuss the toxicities of this treatment
-
10:40 - 10:50
Session I: Prostate Cancer
Using Hydrogel Spacers for Prostate Brachytherapy
Speaker: Aman Taggar, MDDescribe how to apply the Hydrogel spacers
Provide its indication and benefits
Explain rectal toxicity in HDR brachytherapy
-
10:50 - 11:10
Session II: Skin Cancer
Where Does Skin Brachytherapy Stand in 2019
Speaker: Philip Devlin, MDEvaluate the role of brachytherapy for skin cancer
Enumerate the different techniques that can be used
-
11:10 - 11:30
Session II: Skin Cancer
Clinical Aspects of Contact Therapy with Applicators
Speaker: Tim Williams, MDDescribe the different applicators
Describe the dosimetry, advantages, and disadvantages of each applicator
Evaluate dose prescription
-
11:30 - 11:40
Session II: Skin Cancer
Plesiotherapy: 3D Printers
Speaker: Ananth Ravi, Physicienne médicalDescribe indications of 3-D printers for brachytherapy
Explain the technical aspects
Enumerate the steps to create an adequate applicator
-
11:40 - 12:00
Session II: Skin Cancer
Peri-operative HDR Brachytherapy for Keloid Scars
Speaker: James Fotanesi, MDReview the literature supporting this management
Enumerate the indications for this treatment
Discuss the ideal dose
-
12:25 - 13:50
-
13:50 - 14:10
Session III: Lower Digestive Tract Cancers
HDR Endorectal Brachytherapy
Speaker: Te Vuong, MDEnumerate the indications of such a treatment.
Review the side effects and complications of endorectal brachytherapy.
Discuss the technique and the steps involved in endorectal brachytherapy.
Analyse the dose prescription and fractionation of endorectal brachytherapy
-
14:10 - 14:30
Session III: Lower Digestive Tract Cancers
Dose Escalation for Rectal Cancer or Papillon Technique 2.0
Speaker: Rajaram Sripadam, MDAnalyse the technique and the steps involved for Papillon Technique.
Enumerate the indications of such a treatment.
Analyse the dose prescription and fractionation
Explain the results of such a treatment
-
14:30 - 14:50
Session III: Lower Digestive Tract Cancers
Dosimetry for Endorectal Brachytherapy
Speaker: Slobodan Devic, Physicien médicalExplain the steps for dosimetry in endorectal brachytherapy and Papillon technique
Analyse the optimization process.
Describe the steps for quality assurance.
-
14:50 - 15:20
-
16:15 - 17:45
Mini- Workshops
Each workshop lasts 45 minutes. Each participant may take up to 2 mini-workshops for a total of 1h30 for this activity. In order to assure and adequate discussion and retroaction there will be a maximum of 12 participants per mini-Worshop. You will have to review and evaluate some cases and the anonymized's images sets prior and during the activity and make a decision. Plenty of time is allowed during the session to discuss sensitive points with the monitors. At the end of the session you should have master the objectives
Post TURP prostate implant - When is it safe to do brachytherapy?
- Discuss prebrachytherapy imaging
- What to be aware of?
- Evaluate
G. Morton, C .Salembier, A. G. Martin Dosimetry for intraoperative brachytherapy and contact therapy - Recognize the different ways in dosimetry
- Discuss the advantages of volumetric dosimetry
- Discuss pointers
- Evaluate
S. Enger, S. David, S. Devic Skin Applicators - How to use the different applicators
- Discuss Dosimetry
- What to be aware of
- Evaluate
P. Devlin, T. Williams, T. Derashodian Hand on prostate implant - Discuss the different steps
- Discuss Number of needles in HDR
- Evaluate
A. Martinez, M. Jolicoeur, -
18:30 - 20:30
-
07:45 - 08:00
-
08:00 - 08:05
-
08:05 - 08:20
Session IV: Teaching Brachytherapy
-
08:20 - 08:40
Session IV: Teaching Brachytherapy
Teaching Prostate Implantation by Simulation
Speaker: Marjory Jolicoeur, MDReview the literature about virtual teaching by simulation in the medical field
Establish possible pplications in brachytherapy teaching
-
08:40 - 09:00
Session V: Technical Innovations
-
09:00 - 09:30
Session V: Technical Innovations
Intensity Modulated Brachytherapy
Speaker: Shirin Enger, Physicienne médicalExplain the basic principles
Explain the subtleties of dosimetry for IMBT
Explain the behavior of Ytterbium
Identify the advantages of the different isotopes used in HDR brachytherapy
-
09:30 - 09:40
Session V: Technical Innovations
Robotic Needle Insertion or Adaptive MR-Guided HDR Prostate Brachytherapy
Speaker: Luc Beaulieu, Physicien médicalrobotic brachytherapy systems
needle MR-compatible robotic system
Task Group AAPM
Discuss Robot-assisted needles insertion under magnetic resonance imaging (MRI) guidance
-
09:40 - 09:50
Session V: Technical Innovations
3D-TRUS-EMT Image Guided HDR prostate Brachytherapy: System Integration and Validation
Speaker: Luc Beaulieu, Physicien médicalDiscuss real time ultrasound image guidance
Discuss pointers intraoperative vs postimplant dosimetry
Accuracy of MRI/ultrasound-guided
Discuss deformable versus rigid image fusion
-
09:50 - 10:20
Session V: Technical Innovations
Targeting Tumors with Alpha Emitters: AlphaDaRT
Explain the basic principles
Explain the subtleties of dosimetry
Explain the behavior of alpha emitters
Explain the possible clinical applications
-
10:20 - 10:50
-
10:50 - 11:10
Session VI: Gynecological Cancers
Brachytherapy in Medically Inoperable Endometrial Cancer
Speaker: Luis Souhami, MDReview the literature
Identify the indications and benefits of brachytherapy in these clinical situations
Discuss the US Guidelines for Brachytherapy
Discuss the results of this treatment
-
11:10 - 11:30
Session VI: Gynecological Cancers
3D Transrecal Ultrasound for Intersitial HDR Brachytherapy
Speaker: Eric Leung, MDIdentify indications and advantages of the US guidance
Master needle placement in interstitial Brachytherapy
Explain the technique for US guidance
-
11:30 - 11:50
MRI for 3-D Image Guided Cervix Brachytherapy
Speaker: Nicole Nesvacil, Physicien médicalIdentify the indications and advantages of MRI use in this clinical situation
Review GEC-ESTRO recommendations
Discuss the progress of the EMBRACE protocol
-
11:50 - 12:00
Session VI: Gynecological Cancers
Organ Preservation: Brachytherapy for Vulvar Cancer
Speaker: Marjory Jolicoeur, MDIdentify the localizations which will benefit the most from organ preservation
Review the literature
Discuss the results of such a treatment
-
12:00 - 13:10
-
13:10 - 13:30
Session VII: Breast Cancer
In Vivo Dosimetry
Speaker: Nicole Nesvacil, Physicien médicalRecognize the necessity of in vivo dosimetry in a breast implant
Identify the steps for in vivo dosimetry
Identify the most useful situations for in vivo dosimetry
-
13:30 - 13:50
Session VII: Breast Cancer
Electronic Brachytherapy
Speaker: Marija Popovic, Physicienne médicalExplain the basic principles of electronic brachytherapy
Explain the subtleties of dosimetry
Identify the advantages of electronic brachytherapy
-
13:50 - 14:10
Session VII: Breast Cancer
Intra-operative Brachytherapy
Speaker: Tarek Hijal, MDReview the literature
Explain the indications and the results of this treatment
Identify the toxicities of this treatment
-
14:10 - 14:25
Session VII: Breast Cancer
Interstitial Brachytherapy for partial breast irradiation
Speaker: Marie Lynn Racine, MDReview the literature concerning partial breast irradiation
Explain the results of this treatment
-
14:35 - 14:55
Session VII: Breast Cancer
Breast Brachytherapy with Mobetron
Speaker: Kathleen Horst, MDExplain the basic principles of Mobetron
Explain the subtleties of dosimetry for Mobetron
Identify the indications and the advantages of this treatment
Review the literature results
-
14:55 - 15:55
Session VII: Breast Cancer
Discussion
Moderator : Marjory Jolicoeur, MDDiscuss controversil topics about brachytherapy
Question period
-
08:09 - 10:49
Session I: Prostate Cancer
Session I: Prostate Cancer
Moderator : Tamim Niazi, MDDiscuss current standards and future innovations in prostate cancer brachytherapy
Each Talk include a 5 mn question period
-
08:39 - 10:20
Session V: Technical Innovations
Session V: Technical Innovations
Moderator : Dany Truchon, Physicien médicalDiscuss technical innovations in brachytherapy
Each talk includes a 5mn question period
-
10:49 - 12:00
Session VI: Gynecological Cancers
Session VI: Gynaecological Cancers
Moderator : Thu Van Nguyen, MDDiscuss innovations in gynaecological brachytherapy
Each talk includes a 5mn question period
-
10:49 - 12:25
Session II: Skin Cancer
Session II: Skin Cancer
Moderator : Boris Bahoric, MDDiscuss brachytherapy in cutaneous tumors
Question period at the end of the session
-
12:00 - 12:25
Session II: Skin Cancer
-
13:49 - 14:50
Session III: Lower Digestive Tract Cancers
Session III: Lower Digestive Tract Cancers
Moderator : David Donath, MDDiscuss the use of brachytherapy in rectal and anal cancer
Each talk include a 5 mn question period
-
15:20 - 16:00
Session IV: Young Investigators
Abstracts selected for oral presentation
Each talk includes a 3 mn question period
-
15:20 - 16:10
Session IVa: Young investigator
Oral presentations
Moderators : Dany Truchon, Physicien médical & Alvaro Martinez, MD & Luis Souhami, MD15:20 7-24 Urethra-Sparing with Intensity Modulated Brachytherapy for Prostate Cancer Gabriel Famulari Mcgill University
15:30 7-20 MR-Compatible Intensity Modulated Brachytherapy for the Treatment of Locally Advanced Cervical Cancer Marc Morcos, & Shirin A. Enger
Mcgill University
15:40 7-23 TRUS/MRI-Guided Tumor-Targeted Salvaged HDR brachytherapy for Recurrent Prostate Cancer Early Experience at CHUM Christian Arias, Guila Delouya, Daniel Taussky, Maroie Barkati, Marie-Claude Beauchemin, Samuel Kadoury, Dominic Béliveau-Nadeau, Yannick Hervieux, Jean-Francois Carrier, Cynthia Ménard.
Montreal University
15:50 7-15 Isodose surface volumes in cervix brachytherapy: dependence on image guided adaptation and applicator Monica Serban1,2, Christian Kirisits, Karen Nkiwane, Isabelle Dumas, Jamema Swamidas, Astrid de Leeuw, Robert Hudej, Gerry Lowe, Nicole Nesvacil, Richard Pötter, Jacob Lindegaard, Kari Tanderup
Mcgill University, Aarhus University Hospital Denmark, Medical University of Vienna
-
13:09 - 15:55
Session VII: Breast Cancer
Session VII: Breast Cancer
Moderator : Boris Bahoric, MDDiscuss current standards and coming innovations in breast brachytherapy
Question period at the end